It remains to be seen if PARP14 also plays similar roles in other types of cancer and whether the reversal of the TAM phenotype by PARP14 inhibition effectively unleashes anti-tumor effector mechanisms of the adaptive immune system. The gene discussed is PARP14; the disease is neoplasm.